188
Participants
Start Date
November 16, 2017
Primary Completion Date
November 23, 2019
Study Completion Date
November 23, 2019
KAE609
Exploration of different doses of KAE609 to establish safety profile.
Coartem
Control Arm
Novartis Investigative Site, Lambaréné
Novartis Investigative Site, Kintampo
Novartis Investigative Site, Navrango
Novartis Investigative Site, Bamako
Novartis Investigative Site, Sotouba
Novartis Investigative Site, Kigali
Novartis Investigative Site, Bushenyi
Novartis Investigative Site, Kampala
Novartis Investigative Site, Tororo
Lead Sponsor
Wellcome Trust
OTHER
Novartis Pharmaceuticals
INDUSTRY